| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |